Literature DB >> 7400118

Reduction of methemoglobin through flavin at the physiological concentration by NADPH-flavin reductase of human erythrocytes.

T Yubisui, M Takeshita, Y Yoneyama.   

Abstract

The reduction of methemoglobin by NADPH-flavin reductase of human erythrocytes through flavin was studied under various conditions using a reconstituted methemoglobin reductase system. The reduction of methemoglobin by the reconstituted enzyme system could be easily detected with flavin at the physiological concentration (e.g., 0.1-1.0 microM), and the rates obtained with 0.1 and 1.0 microM FMN were 0.19 and 2.2 nmol heme reduced per min per ml, respectively, in the absence of oxygen. FMN was more effective than FAD in reduction by the reconstituted enzyme system, and oxygen decreased the rate of the reduction. The reduction of methemoglobin by the reconstituted enzyme system with flavin at a physiological concentration proceeded as a zero order reaction. These results apparently suggest that the NADPH-flavin reductase system is able to reduce methemoglobin in erythrocytes at a moderate speed with about 1 microM flavin, and the reduction was estimated to vary from less than 1% to about 20% of that by the NADH-cytochrome b5 reductase system with 1 microM cytochrome b5, depending on the uptake of flavin by human erythrocytes.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7400118     DOI: 10.1093/oxfordjournals.jbchem.a132915

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  11 in total

1.  Membrane peroxidation and methemoglobin formation are both necessary for band 3 clustering: mechanistic insights into human erythrocyte senescence.

Authors:  Nobuto Arashiki; Naoki Kimata; Sumie Manno; Narla Mohandas; Yuichi Takakuwa
Journal:  Biochemistry       Date:  2013-08-16       Impact factor: 3.162

2.  Methaemoglobinaemia in a G6PD-deficient child treated with rasburicase.

Authors:  Thomas Bontant; Sophie Le Garrec; David Avran; Stephane Dauger
Journal:  BMJ Case Rep       Date:  2014-08-12

3.  Reduction of ferric leghemoglobin in soybean root nodules.

Authors:  K K Lee; R V Klucas
Journal:  Plant Physiol       Date:  1984-04       Impact factor: 8.340

4.  The Zebrafish Cytochrome b5/Cytochrome b5 Reductase/NADH System Efficiently Reduces Cytoglobins 1 and 2: Conserved Activity of Cytochrome b5/Cytochrome b5 Reductases during Vertebrate Evolution.

Authors:  Matthew B Amdahl; Elin E Petersen; Kaitlin Bocian; Stefan J Kaliszuk; Anthony W DeMartino; Sagarika Tiwari; Courtney E Sparacino-Watkins; Paola Corti; Jason J Rose; Mark T Gladwin; Angela Fago; Jesús Tejero
Journal:  Biochemistry       Date:  2019-07-10       Impact factor: 3.162

5.  PharmGKB summary: methylene blue pathway.

Authors:  Ellen M McDonagh; José M Bautista; Ilan Youngster; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2013-09       Impact factor: 2.089

6.  Familial Congenital Methemoglobinemia in Pomeranian Dogs Caused by a Missense Variant in the NADH-Cytochrome B5 Reductase Gene.

Authors:  H Shino; Y Otsuka-Yamasaki; T Sato; K Ooi; O Inanami; R Sato; M Yamasaki
Journal:  J Vet Intern Med       Date:  2018-01-22       Impact factor: 3.333

7.  A new mutation of congenital methemoglobinemia exacerbated after methylene blue treatment.

Authors:  Fuminori Yamaji; Akio Soeda; Hiroki Shibata; Takuya Morikawa; Kodai Suzuki; Shozo Yoshida; Shinji Ogura
Journal:  Acute Med Surg       Date:  2018-02-15

8.  Not the Typical Pneumonia: An Unusual Case of Rasburicase-induced Methomoglobinemia.

Authors:  Moustafa Younis; Laith Derbas; Stephen M Eikermann; Majdi S Hamarshi
Journal:  Cureus       Date:  2018-08-01

9.  Efficient Reduction of Vertebrate Cytoglobins by the Cytochrome b5/Cytochrome b5 Reductase/NADH System.

Authors:  Matthew B Amdahl; Courtney E Sparacino-Watkins; Paola Corti; Mark T Gladwin; Jesús Tejero
Journal:  Biochemistry       Date:  2017-07-19       Impact factor: 3.321

10.  Activities of three erythrocyte enzymes of hyperglycemic rats (Rattus norvegicus) treated with Allium sativa extract.

Authors:  Paul C Chikezie; Augustine A Uwakwe
Journal:  J Diabetes Metab Disord       Date:  2014-04-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.